SEATTLE, July 05, 2021, (MEDGADGET) — Global Chemiluminescence Imaging Market
Chemiluminescence is the process of converting chemical energy into visible light that is emitted as a result of oxidation or hydrolysis. This process offers sensitive, as well as cost-effective detection methods, radio-isotopic and fluorescence techniques, along with the most chromogenic detection processes. Chemiluminescence imaging plays a key role in capturing the series of images during the identification of low-abundance proteins. Chemiluminescence imaging therefore enables accurate quantification of Western blots, with a real-time display.
Get Sample PDF Brochure with Impact of COVID19: https://www.coherentmarketinsights.com/insight/request-pdf/2497
Global Chemiluminescence Imaging Market Dynamics
Increasing use of chemiluminescence imaging in various sectors, such as medical & forensic sciences and in DNA and protein detection, is expected to boost the global chemiluminescence imaging market growth. Moreover, new product launches is foreseen to bolster the global market growth. For instance, in 2017, Bio-Rad Laboratories Inc. launched ChemiDoc MP Imaging System. It offers high-resolution DNA and protein gel documentation features and its chemiluminescence detection sensitivity matches that of the conventional X-ray film. It can be used for both fluorescent and chemiluminescence detection. Moreover, in June 2019, Thermo Fisher Scientific Launched Powerful Invitrogen iBright 1500 Imaging System Series for Western Blot and Gel Imaging. This iBright 1500 series can be utilized to image fluorescent western blots, chemiluminescent western blots, nucleic acid gels, and more.
Similarly, in February 2018, Pop-Bio Ltd. introduced its novel Pop-Bio Imaging system (Vü) that utilizes the Advanced Progressive Imaging technology to accurately capture images at ultra-high sensitivity and resolution. This can be used in a wide range of applications, including UV, blue light, blue-green, visible light, and chemiluminescence.
Tailored Information as per niche requirement:
LIMITED TIME OFFER – Hurry Up!
Exclusive offer!!! Purchase the report at a discounted rate!!!
Get Discount For Buyers UPTO 30% OFF On Any Research Report
Buy Now with Discount for Premium Report 2021: https://www.coherentmarketinsights.com/promo/buynow/2497
Global Chemiluminescence Imaging Market – Regional Outlook
The global chemiluminescence imaging market is geographically segmented into North America, Latin America, Europe, Asia Pacific, Middle East, and Africa. However, North America is expected to hold the most dominant position in the global chemiluminescence imaging market, supported by the increasing research studies for forensic human identification by using methods, such as DNA profiling, forensic anthropology, forensic radiography, and forensic odontology, in which chemiluminescence imaging plays a crucial role.
Furthermore, Europe is expected to witness significant growth in the global chemiluminescence imaging market, owing to launch of new products in the region. For Instance, in 2017, Syngene, a manufacturer of image analysis solutions, launched its new GeneGnome XRQ — a dedicated chemiluminescence imaging system. The new GeneGnome XRQ is designed to rapidly and accurately image chemiluminescent Western blots. It consists of high-quality F/0.95 fixed focus, cooled camera with on chip integration and GeneSys software.
Global Chemiluminescence Imaging Market – Competitive Scenario
The well-known players operating in the global chemiluminescence imaging market include LI-COR Biosciences, Analytik Jena US, Azure Biosystems, Berthold Technologies GmbH & Co. KG, Bio-Rad Laboratories, Inc., Cleaver Scientific Ltd, Next Advance, Inc., Syngene, GE Healthcare, Vilber Smart Imaging, Inc., Thermo Fisher Scientific, Analytik Jena Life Science, PerkinElmer, Inc., and ANALIS.
To get detailed table of content (ToC), please click – https://www.coherentmarketinsights.com/ongoing-insight/toc/2497
In August 2017, Azure Biosystems Inc., launched Sapphire Biomolecular Imager, a next-generation laser scanner system, which offers fluorescent imaging in the Near IR (NIR) and Visible Wavelengths (RGB), true chemiluminescent imaging.
Furthermore, in September 2017, DiaSorin S.p.A. acquired ELISA technology business from Siemens. The objective of acquisition was to convert the current client base that uses ELISA tests towards CLIA technology solutions.
Global Chemiluminescence Imaging Market Taxonomy
- Chemiluminescence Immunoassay
- DNA hybridization
- Western Blotting
- Southern Blotting
- Hormones (Insulin, Thyroxin, and Estradiol)
- Vitamin (Vit 12)
- Forensic Sciences
- Southern Blotting
- Tumor Markers
By End User,
- Diagnostics Laboratory
- Research and Academic Institutes
- Forensic Laboratories
- North America
- Asia Pacific
- Latin America
- Middle East
Table of Content
Global Chemiluminescence Imaging Market Research Report
Section 1: Global Chemiluminescence Imaging Industry Overview
Section 2: Global Economic Impact on Chemiluminescence Imaging Industry
Section 3: Global Market Competition by Industry Producers
Section 4: Global Productions, Revenue (Value), according to Regions
Section 5: Global Supplies (Production), Consumption, Export, Import, geographically
Section 6: Global Productions, Revenue (Value), Price Trend, Product Type
Section 7: Global Market Analysis, on the basis of Application
Section 8: Chemiluminescence Imaging Market Pricing Analysis
Section 9: Market Chain, Sourcing Strategy, and Downstream Buyers
Section 10: Strategies and key policies by Distributors/Suppliers/Traders
Section 11: Key Marketing Strategy Analysis, by Market Vendors
Section 12: Market Effect Factors Analysis
Section 13: Global Chemiluminescence Imaging Market Forecast
Other Related Reports:
Medical Holography Market by Product Type, by Hologram Type, by Technology, by Application, by End User, and by Region – Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2021- 2028
Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having office at global financial capital in the U.S. and sales consultants in United Kingdom and Japan. Our client base includes players from across various business verticals in over 150 countries worldwide. We pride ourselves in catering to clients across the length and width of the horizon, from Fortune 500 enlisted companies, to not-for-profit organization, and startups looking to establish a foothold in the market. We excel in offering unmatched actionable market intelligence across various industry verticals, including chemicals and materials, healthcare, and food & beverages, consumer goods, packaging, semiconductors, software and services, Telecom, and Automotive. We offer syndicated market intelligence reports, customized research solutions, and consulting services.
To know more about us, please visit our website – www.coherentmarketinsights.com
Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027